软性与数字输尿管镜及增强成像对UTUC诊疗的肿瘤学结局
基于CROES-UTUC登记研究,比较软性光纤与数字输尿管镜及NBI、Image1-S增强成像对UTUC患者肿瘤学结局的影响。研究纳入401例行输尿管镜患者,发现数字镜未优于光纤镜,增强成像亦未改善总生存和无病生存,提示术者经验与诊疗集中化更为重要。
要点
- 数字输尿管镜相比光纤镜未显示肿瘤学优势。
- NBI和Image1-S未改善总生存或无病生存。
- 应重视术者技能经验并推动UTUC诊疗集中化。
核心结论
- 数字输尿管镜相比光纤镜未提供任何肿瘤学优势。
- 图像增强技术相比数字输尿管镜未改善总生存和无病生存。
研究设计与样本
- CROES-UTUC为国际多中心前瞻性队列研究,来自101个中心、37个国家共2380例患者。
- 其中401例行输尿管镜,光纤镜186例、数字镜215例。
主要发现
- 5年总生存率为91.5%,5年无病生存率为66.4%。
- 光纤镜组平均总生存42个月、数字镜组39个月(P = 0.9);平均无病生存分别为28个月和21个月(P < 0.001)。
- 在以治疗为目的的输尿管镜患者中,两组总生存(P = 0.9)和无病生存(P = 0.7)无差异。
- NBI和Image1-S技术未在数字输尿管镜基础上改善总生存或无病生存。
- 两组术中及术后并发症无差异。
临床怎么用
- 选择光纤或数字输尿管镜及是否使用增强成像时,不应以肿瘤学结局作为决策依据。
- 应重视术者技能与经验,并推动UTUC诊疗的集中化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare the oncological outcomes of patients with upper tract urothelial carcinoma (UTUC) undergoing kidney-sparing surgery (KSS) with fibre-optic (FO) vs digital (D) ureteroscopy (URS). To evaluate the oncological impact of image-enhancement technologies such as narrow-band imaging (NBI) and Image1-S in patients with UTUC. PATIENTS AND METHODS: The Clinical Research Office of the Endourology Society (CROES)-UTUC registry is an international, multicentre, cohort study prospectively collecting data on patients with UTUC. Patients undergoing flexible FO- or D-URS for diagnostic or diagnostic and treatment purposes were included. Differences between groups in terms of overall survival (OS) and disease-free survival (DFS) were evaluated. RESULTS: The CROES registry included 2380 patients from 101 centres and 37 countries, of whom 401 patients underwent URS (FO-URS 186 and D-URS 215). FO-URS were performed more frequently for diagnostic purposes, while D-URS was peformed when a combined diagnostic and treatment strategy was planned. Intra- and postoperative complications did not differ between the groups. The 5-year OS and DFS rates were 91.5% and 66.4%, respectively. The mean OS was 42 months for patients receiving FO-URS and 39 months for those undergoing D-URS (P = 0.9); the mean DFS was 28 months in the FO-URS group and 21 months in the D-URS group (P < 0.001). In patients who received URS with treatment purposes, there were no differences in OS (P = 0.9) and DFS (P = 0.7). NBI and Image1-S technologies did not improve OS or DFS over D-URS. CONCLUSIONS: D-URS did not provide any oncological advantage over FO-URS. Similarly, no differences in terms of OS and DFS were found when image-enhancement technologies were compared to D-URS. These findings underline the importance of surgeon skills and experience, and reinforce the need for the centralisation of UTUC care.
引用
- Soria F, Laguna MP, Roupret M, et al. Flexible fibre optic vs digital ureteroscopy and enhanced vs unenhanced imaging for diagnosis and treatment of upper tract urothelial carcinoma (UTUC): results from the Clinical Research Office of the Endourology Society (CROES)-UTUC registry. BJU Int. 2021. PMID: 34028166. doi:10.1111/bju.15494
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。